Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for THERAKOS DEVELOPMENT LIMITED.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
THERAKOS DEVELOPMENT LIMITED: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
Side by side
Philips North America — Warning letters0
THERAKOS DEVELOPMENT LIMITED — Warning letters0
Philips North America — Recalls355
THERAKOS DEVELOPMENT LIMITED — Recalls1
Philips North America — Approval records0
THERAKOS DEVELOPMENT LIMITED — Approval records0
Philips North America — Form 483s0
THERAKOS DEVELOPMENT LIMITED — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs THERAKOS DEVELOPMENT LIMITED: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/philips-north-america-vs-therakos-development-limited
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗